---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-006428"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2023-01-31T23:59:59+00:00"
generated_at: "2026-06-20T05:21:06.070424+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma announces board-authorized stock repurchase program up to $1M

## Summary
- Board authorized repurchase of up to $1M of common stock in open market or privately negotiated transactions.
- Company had approximately 3,138,797 shares outstanding as of November 10, 2022.
- Repurchases subject to available liquidity, cash flows, market conditions, and regulatory limits.
- Program does not obligate the company to repurchase any specific amount and may be suspended or discontinued any time.

## SEC filing metadata
- accession: 0001213900-23-006428
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2023-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/0001213900-23-006428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/ea172375-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-006428
- JSON: https://secwatch.observer/filing/0001213900-23-006428.json
- Plain text: https://secwatch.observer/filing/0001213900-23-006428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.